logo


New Study Finds Workplace Health Care Significantly Increases Adherence to Medications, Potentially Saving Health Care Dollars and Improving Patient Outcomes
Thursday, July 09, 2009 10:06 AM


Findings published in current issue of American Journal of Managed Care show adherence rates nearly 10 percent higher in patients who use integrated workplace primary care and pharmacy services

Non-adherence to medication currently estimated to cost the U.S. healthcare system $100 billion per year due to poorly controlled conditions

A new study shows that patients who use workplace primary care and pharmacy services have higher adherence rates to medications for chronic conditions, suggesting that by investing in integrated workplace health and pharmacy programs companies can realize health care savings while also improving patient outcomes.

The findings, published in the current issue of the American Journal of Managed Care, show that overall adherence to medication was nearly 10 percent (9.72 percent) higher among patients treated in the workplace than those treated in the community. The authors of the study concluded that due to the negative impact on patients’ health and significant costs associated with non-adherence, these results support the concept of workplace health as a means to save “not only health care dollars, but lives as well.”

“This study truly demonstrates the value of the workplace health care model in addressing medication adherence – one of the most challenging and costly obstacles faced by providers and payers of health care,” said Dr. Sharon Frazee, an author of the study and vice president of health research for Take Care Health Systems. “Having care accessibly located at the worksite allows employees to build a trusted, face-to-face relationship with both their clinicians and pharmacists, providing an opportunity to engage in a dialogue about their condition and treatment plan, and ultimately, promote patient adherence through education and communication.”

Low rates of medication adherence are a growing issue for the country’s health, recently referred to as “America’s other drug problem” by The National Council on Patient Information and Education, and can potentially result in serious negative health outcomes for patients.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia